ICLR logo

ICON PLC

ICLRNASDAQ
πŸ† #642 by market capEarnings Feb 24US Equity
β€”β€”
Quote unavailable
πŸ””
Track ICLR
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$13.99B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
2.6%
Slowing
πŸ“ŠGross Margin
23.5%
Moderate
πŸ’΅FCF Margin
10.3%
Healthy
βš–οΈP/S Ratio
1.7x
Cheap
Otter Score
72
Strong
No chart data available for ICLR.

Trading Snapshot

Day Range
β€”
52-Week Range
$66.57 – $219.04
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
74.9M
Next Earnings
2027-02-24

Fundamentals Snapshot

Annual Revenue
$8.25B
Last Q Revenue
$2.02B
P/E Ratio
74.1
P/S Ratio
1.7x
EPS (TTM)
$2.45
Dividend Yield
β€”
Dilution (1yr)
βˆ’4.0%
ICLR logo

ICON PLC

ICLR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8.3Bβ–Ό βˆ’0.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
26.4%β–Ό βˆ’10.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.0Bβ–Ό βˆ’7.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$862Mβ–Ό βˆ’22.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
79.0Mβ–Ό βˆ’4.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2.9Bβ–² +$156M YoY
StockOtter Β· stockotter.space

About ICON PLC

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100
Analyst data unavailable.

Latest News & Updates

News unavailable.